Stats

Premises collected September8 2026: 1. September7 political demand is linked through https://www.trumpstruth.org/?per_page=100 to https://truthsocial.com/@realDonaldTrump/117230978314061095 ; direct post extraction failed. July9 proclamation directs negotiations and an update within180days, not a September sales-ban mechanism: https://www.whitehouse.gov/presidential-actions/2026/07/adjusting-imports-of-commercial-aircraft-jet-engines-and-aircraft-and-engine-parts-into-the-united-states/ . Scoped White House/Commerce/CBP/Federal Register searches found no implementing instrument. Unverified is not nonexistent. 2. Canada operational exemptions include G500/G600/G700/G800 charter operations https://tc.canada.ca/en/aviation/reference-centre/exemptions-canadian-aviation-regulations-cars . They narrow the blanket blocked claim, but do not settle every certification/sales issue. Separate September8 counter-tariffs specify15/25/50%, origin and in-transit exceptions: https://www.canada.ca/en/department-finance/news/2026/08/list-of-products-from-the-united-states-subject-to-counter-tariffs-effective-september-8-2026.html .630-row text screen matched no aircraft/8802/8807/8411; generic components remain unclassified, so no exemption inferred. 3. Bombardier issuer response names Texas wings, California flight controls,2800 US suppliers and>2.5bn annual supplier spending https://finance.yahoo.com/economy/articles/bombardier-statement-004300095.html . Advocacy and US component manufacture do not prove US final assembly or exemption. Its annual PDF endpoint returned challenge HTML, leaving audited US revenue exposure unverified; do not multiply a politician's50% claim by forecasts. 4. Global7500/8000 uses GE Passport https://www.geaerospace.com/news/press-releases/ge-aerospace-shipping-500th-passport-engine ; G700/G800 uses Pearl700, Global5500/6500 Pearl15 https://www.rolls-royce.com/products-and-services/civil-aerospace/business-aviation . Top-end transfer may hurt GE and help Rolls; smaller Global transfer changes Rolls mix. Certified engines are not interchangeable. Textron's3500nm Longitude serves a different mission https://cessna.txtav.com/citation/longitude?trk=NavCitation ; its annual filing warns certified vendor replacement can stop production https://www.sec.gov/Archives/edgar/data/217346/000021734626000006/txt-20260103.htm . Falcon10X service2029 cannot fill immediate demand https://www.dassault-aviation.com/wp-content/blogs.dir/2/files/2026/07/2026-first-half-year-Results-Financial-Release.pdf . 5. GD's full2025 risk factors warn one/two suppliers, qualified labor, certification delays and demand cyclicality;70% government revenue and38% aircraft backlog outside North America complicate pure US substitution exposure https://www.sec.gov/Archives/edgar/data/40533/000004053326000006/gd-20251231.htm . Conclusion: conditional GD beneficiary, divided upstream incidence, no proven immediate rent. Start: cash278.67, no holdings. Goal: accepted incremental production with retained cash contribution. Binding constraint: deliverable uncommitted capacity plus effective policy scope. Prior automatic-Gulfstream-benefit idea downgraded to watch; a signed instrument plus documented incremental profitable deliveries changes operational status to supported, but allocation remains zero until independent net payoff validation. No calibrated policy probability available. Validity of conditional chain is sound; soundness cannot establish it occurs today. Counterexamples: canceled slots enable rapid transfer; overseas buyers replace US buyers; tariff remission averts disruption; supplier inflation absorbs premium. Facts are dated disclosures; all order-transfer effects are hypotheses. Independent origins: political speaker, US government, Canadian government, Bombardier, GD, GE, Rolls, Textron, Dassault; syndications count once.

Premises: 1 Business risk can persist after earnings; counterexample to automatic volatility decay is deteriorating renewals or rising platform costs. 2 Current operating strength does not establish stock fair value or future tail frequency. 3 A dated no-dividend policy supports a model input, not irrevocable cash rights. September3 issuer Q2 disclosure is positive framing; GAAP operating margin7.80% and OCF margin7.56% temper extrapolation from80% gross margin. ARR is not revenue guidance. March25 FY2026 10K identifies renewal and third-party infrastructure dependencies and no anticipated dividends. Thus persistent business uncertainty and a one-off earnings repricing can both be true. No enterprise-value estimate from weighted-average shares; current shares and full debt adjustments were not verified. Unit-economics and tail-probability mapping remains absent. Transcript403 limits causal attribution. These sources do not turn a bearish narrative into cheap optionality. Sources https://ir.uipath.com/news/detail/461/uipath-reports-second-quarter-fiscal-2027-financial-results ; https://ir.uipath.com/financials/sec-filings/content/0001734722-26-000012/path-20260131.htm .

Derivedfromobs12330 https://attachment.news.eu.nasdaq.com/aa8bae6e3da62b95404c23eb6ec2cc25a andstaleSep4price https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST . CashdividedbyQ2operating+investingburn gives11.75months fromJun30; includingQ2debt/leaserate10.78months, notmanagementrunwayguidance. Samecostquarterimplies273.1MSEK afterQ3; actualcosts/receivables/discounts/launchmaydiffer. Ordinarysharegrowth17.66% year-to-Jun30; raise fee5.4%; ordinaryequity3.580bnSEK/~51.44xannualizedQ2sales69.6MSEK, neitherEVnorforwardrevenuevaluation. NoSEKUSDconversionimputed. Assumedvoucher netsales100/150/200MUSD yields50/75/100 retainedbeforeunmodeledtax/timing; thisiscontingentscenario,notsalequote. Premises: positivecashmostlyfinancing,launchvaluealreadyrequiredbyhighcurrentsalesmultiple,benefitsharesplit. Conclusionnotnear-termcashcrisisatflatburn,notfreevoucherarbitrage; strongestbullfutureUSsales+voucher couldtransformcashbutwecannotpriceapprovalorpre-eventdrift. ConfidentialUSnetprice/payeruptakeandfinalsurvivalpackage gaps preventDCFfalseprecision.

1. EWJ issuer snapshot is recorded in observation12340; share price, NAV, non-fair-valued NAV and foreign security/FX clocks differ. These differences do not themselves establish executable arbitrage.2. Twelve country wrappers aggregate underlying business and currency exposures. A price decline may reflect new information about expected cashflows or discount rates; it need not be temporary inventory pressure. NAV creation/redemption economics link the wrapper to underlying value, but our small book trades secondary shares, not institutional baskets.3. Our inference: country-level weakest-return selection may repeatedly buy high-volatility country/sector exposure. The US-session signal probes timing, not a clean causal decomposition of information and liquidity. Need matchedbenchmark and selectionconcentration statistics before claimingalpha.4. No point-in-time constituent fundamentals or historical FXhedge series were collected; current EWJ valuationcannotbe backfilledas2016-25 signal. Issuerexpense is in fund marketperformance; do notsubtract ittwice. Spreadandstop costs remain separate assumptions. Source https://www.ishares.com/us/products/239665/ishares-msci-japan-etf ; historicalsource https://runway.adityaperswal.workers.dev/data/stock-bars . Conclusion structural plausibility is insufficient fortrade,allocation0pendingfrozenvalidation.

Start state allcash, goal reliable after-cost profit; binding constraint independent event-price edge and demonstrated service. Premise1 observations12341/12342 verify raw on-chain signatures against issuer-domain public key, supporting attribution of a patch statement and affirmative reply. This supersedes blanket missing authenticated repair statement; mathematical verification does not establish current custody keys or complete revocation audit. Premise2 direct operator post12343 datedSep8 01:00:47UTC says software deployed and preparing coordinated restart, not completedrestart. Premise3 full history12335/12336 shows3400BTC principal returned plus.00008 message-carrierBTC,598.4998345recipient,3597.47197696watchedreserve,zero subsequent confirmed reserve spend. Premise4 liabilities and all federation addresses are not enumerated; oneaddress cannot establish reservecoverage. Conclusion repair progresses, but cannot infer redeemability or a BTC buying edge. Validity: returnedassets+statement do not logically imply successfulwithdrawals. Soundness bounded by indexed transactions, HTTPS key and operator self-report; counterexample authorized new wallets could be paying even without watchedaddressspend. Operator/bridge users benefit if repair restoresconversion; intermediary incentives favor reassurance, so verify realizedpayout. Source https://blockstream.com/pgp.txt ; https://blockstream.info/api/tx/3c101c8e053a6cbc7c4455e4fec017c8f2962ed86dee70e72fb8bafbb1d7bde9 ; https://x.com/Blockstream/status/2097127976672342487 ; https://blockstream.info/api/address/bc1qdlld6antmv4xug242ed83q7k4rqw50cwfns38szx4qu2f4jwaxxsuhwxxr/txs/chain . Prior uncertainty narrows to currentkeys/liabilities/payouts; new verified current payout plus issuerrecovery statement would change service status, not automatically allocation.

Premises1 EMA independent assessment supports peripheral-thyrotoxicosis indication (https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate).2 ReTRIACt biochemical endpoint positive but rescue endpoint negative, neurological trialnegative; differentendpoints makebothpartlyright, not contradiction (obs12332–34).3 Currentregistry https://clinicaltrials.gov/api/v2/studies/NCT05579327 has completionbefore sponsor-describedSAPrevision; historicalSAP/unblindingnotobtained, so prospectivehierarchyunresolved.4 Survivalabstract https://www.endocrine-abstracts.org/ea/0101/ea0101op-03-04 has selection/residencyimbalance andauthorsflagconfounding/immortaltime; laterN>600notindependentlyaudited. CONCLUSION clinicalbenefitplausible, but neither approvalprobability norpre-eventreturnquantifiablefromthese data. Validity: uncertainfinancialedgecannotfollowfromclinicalp-value. Soundnesslimitedversions/missingpatientdata. Strongcounterargument: rare-disease totality plusEUauthorization mayjustifyFDAapproval despitefailedendpoints; agreed,therefore notbearishapprovalprediction. Prior broadbiochemicalbenefitconfidence strengthened; tradeprobabilityremainsunidentified. Tochange allocationneedcostrobustindependentactual-window eventcohort plus executablevenue; positiveFDAdecisionalone comesafterrunupwindow.

1. Final screened MRNA63dayreturn206.8086%,annualvol365.8057%,Sep4C145.55,ATR14=22.7965. Largest sampled dayAug19O116.02/C174.38,closeclose+176.9695%; oneevent dominates volatility. 2. JointissuerAug19 06:45EDT states INTerpath001 intismeran+KEYTRUDA met primaryRFS/keysecondaryDMFS atprespecified interim; OScontinues, no new safety signals claimed. No hazardratio/CI supplied in fetched release; future meeting data and filing discussions are not approval. https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/ . 3. ANF63dayreturn98.6594%,vol86.4701%,C149.67,ATR8.7771. Aug26issuer blog says15consecutive sales-growthquarters,recordsales andraisedFYoutlook; links to externalcoverage, so no preciseEPSbeat inferred. https://corporate.abercrombie.com/blog/af-co-announces-q2-earnings/ . 4. One-share1ATR risk22.80/8.78 exceeds8.5099budget forboth; fractional sizing would not supply a missing edge or permit aroundclockfractionalexits. These are retrospectively selected winners and old publicevents, not out-of-sample PEAD samples. Strong clinical/economic news is the positive counterexample, but paid price and entry delay govern returns. Conclusion no proposal; retain events for complete prospective studies including failures, avoid reusing priorlosingPEADtrade probabilities. Sources for prices https://runway.adityaperswal.workers.dev/data/stock-bars .

1. Initial incomplete Nasdaq-heavy screen (superseded by full-format repair) selected SLAB vol3.9644%,CZR10.1093%. Retain findings with that selection provenance; neither is finaltop600lowvolleader. 2. Feb4jointissuer release says TXN cash offer231 forSLAB,EV7.5bn,expectedH12027 subject approvals. AtSep4 220.58 spread4.7239%;1share exceeds212.7475positioncap. https://silabs.gcs-web.com/news-releases/news-release-details/texas-instruments-acquire-silicon-labs . 3. May28issuer says Fertitta cash31forCZR,EV17.6bn including11.9bndebt,no financing condition but shareholder/regulatory conditions. Sep4 29.68 gives4.4474%grossspread. https://investor.caesars.com/news-releases/news-release-details/caesars-entertainment-enters-agreement-be-acquired-fertitta . 4. Approximate unaffected price31/1.49=20.8054 from rounded49%offerpremium is a stress assumption, not a forecast of break value. That implies8.8746USD lossperwhole share, above8.5099accountrisk. Deal-success breakeven probability about87.05% before costs/time from this binary assumption is NOT estimated success probability. No calibrated deal-history sample or current approval underwriting; quarterKelly cannot be inferred,actual0. 5. First-order quiet spread rewards completion; second-order financing/regulatory failure makes returns discontinuous; third-order low-vol ranking systematically attracts apparently safe positions whose stop cannot cap gap loss. Merger advisors collect completion fees, bidder seeks strategic value, sellers receive conditionalcash; none establishes our expectedreturn. Conclusion reject lowvolclassification for trading and no standalone merger proposal. A verified independent net deal cohort would change research eligibility; narrow realizedATR does not.

1. Preset29-name international sample yields28price series; raw local-currency closing returns are not USD totalreturns. ALV.DE low-vol leader: Sep4 EUR450.60,63dayvol12.0721%,momentum19.2379%; German lastavailableSep4 is not asserted currentSep7close. Aug7 issuer Q2 operatingprofit4.9bnEUR+10.6%, but coreincome2.6bn-12.7% reflects divestment comparison; underlying growth10% is management adjustment. P&C combinedratio91.9% versus91.2% worsens even as profit grows; solvency225% based on quarterly accrual, annualdividend accrual would subtract7points. https://www.allianz.com/en/mediacenter/news/media-releases/financials/260807-2q-2026-earnings-release.html . 2. SHOP.TO momentum leader+31.3960%,vol58.2366%,CAD200.76 Sep4. Aug5issuer Q2 revenue3583mUSDvs2680,OCF658-capex4=FCF654,18%margin; grossprofit1708,operating488. Q3revenuegrowth low30s versus grossprofit mid-high20s and150mSBC guidance means growth and dilution/mix warrant joint assessment. https://www.shopify.com/investors/press-releases/shopify-delivers-big-30-growth-across-gmv-revenue-gross-profit . 3. Both statements are public month-old issuer claims, not a fresh surprise. Currency/venue eligibility and independent strategy validation unresolved; local listing plus US listing are same issuer, not independent signals. Conclusion retain research watch, allocation0. Strongest counterargument is genuine cash growth; evidence that would change eligibility is prospectively validated net price-rule performance, not a larger headline growth number.

1. Final US screen ranks BRK.B lowest volatility among positive-momentum, non-ETF names in the 600-name panel: 63-day vol14.6672%, return3.6671%, Sep4price506.03. Aug8 issuer Q2 release reports operating earnings12983m vs11160m (+16.34%), while underwriting1731m vs1992m and investment income3059m vs3367m decline. Investment marks explain much of GAAP net25667m. Insurance float177.5bn is a liability-backed funding structure, not risk-free cash. https://www.sec.gov/Archives/edgar/data/1067983/000119312526344495/d159922dex991.htm . One whole BRK.B share exceeds212.7475positioncap; fractional purchase still requires independent netedge. 2. O: Sep4price61.25,vol17.579%,momentum1.981%,below100dayMA62.0381. IssuerQ2 AFFO/share1.09 vs1.05, FYguide4.44-4.45raised, but GAAPEPS1.59-1.60lowered; occupancy98.8% vs98.9%March/98.6%prior-year. ForwardAFFO multiple13.7795 versus GAAP38.4013 reflects definitions, not arbitrage. https://www.sec.gov/Archives/edgar/data/726728/000072672826000044/o-991q22026.htm . 3. Binding constraint is validated implementable payoff, not liquidity: median20day traded dollars BRK.B2.158bn/O293.6m far exceed book245.69. Positive operations support watch status but no identified near-term mispricing, own issuer claims not independent corroboration. Counterexample: durable businesses can appreciate while we holdcash; that does not establish monthly ATR-entry expectancy. Conclusion no proposal; source dates and contradictory components retained, zero probability calibration imported from quality labels.

Sep1issuerPDF reportsAugust0shares/JPY0repurchasedandcumulative0underOct28 2025resolution.Authority150mshares/JPY75bnthroughOct28 2026;issuedex-treasury1,345,313,741Aug31.Premises1 authorizedceilingnotcashdemand;2 noexecutedAugustsupport;3 currentlyverifiedBTCNAV/dilutedcapitalandFXexecutionmissing.Conclusionrejectbuyback-floorentry,retainresearchonly.CounterexampleissuercouldstartinSeptember,butthatrequiresnewdisclosedexecution,notassumption.FromOct29starttoAug31cumulativeexecution0%ofceiling;not75bnactualsupport. CurrentYahooJPXquote263JPYtimestampSep8 01:56,versusSep7bar271≈−2.95%,20bar+12.88%;earlierCLI−12.33%uses5dchartbaselineNOTdailyreturn. Identityconfirmed3350Metaplanet. Who benefitsfromheadlineauthorizationexistingholders;firstorderactualbuybacksreducecash/shares,secondorderchangeBTCpershareandfunding,thirdorderpremiumdynamicsmayaltertreasurygrowth,butzerodisclosedexecutioncannotpowerthatcausalchain. Source https://contents.xj-storage.jp/xcontents/33500/16a47b00/00a7/418e/b278/f006c235f57e/140120260901530010.pdf ; https://query1.finance.yahoo.com/v8/finance/chart/3350.T . No priceedgebacktest/numericKellyforproxy;allocationzero.

Premises1 IBITissuerreadSep8shares1,384,960,000andassets62.524bnstillasofSep4; Sep7benchmarkisadifferentdatedfield.2 CircleUSDC74.33bnasofSep3 isalevel;7/30dayissuance/redemptionfieldsblankinrenderingnotzero.3 Noneisfreshnetcryptobuyflow. Conclusionretainbaselineswithoutbullishflowclaim. Newsharecountsnormalizedforcorporateactionsorissuerdatednetmintseriescouldchangeassessment; priceedgewouldremainseparategate. Counterexample realovernightstablecoinmintingcouldhappenwithoutpageupdate; absenceofevidenceisnotoutflow. Sources https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf ; https://www.circle.com/use-case/treasury-management ; https://www.circle.com/transparency . Existingmonitor44coverspostholidayissuer/macroreview; no duplicatecatalyst.

Aug27issuerFY26report Q4AI70.5m/mining66.7m,total137.2m: AI51.385%ofQ4revenue vs23.204%Q3; mining fell40.018%QoQ,total fell5.249%,adjEBITDAmargin13.994%versus41.091%. OperatingARR1bn vscontracted4bn2026capacity; ARRnotGAAPandacceptancematters. New2.4bnGPUfinancing9%implies216m/year simplefull-balanceinterestbeforeamortization/fees; hypotheticalratebridge,notactualexpense. Premises1 miningbeingdecommissioned;2 AIrequirescustomeracceptanceandcapital;3 Sep4+7.30%IEXmove notattributedtocryptocatalyst. ConclusionrejectIRENasstraightBTCproxy; betterresearchedthroughAIinfrastructurefundamentalmandate, noFUNDproposalwithouttestededge. Counterexample risingBTCcouldstillhelpremainingmining, butdoesnotvalidateequitypayoff. Source https://iren.gcs-web.com/static-files/1cb9f4da-d4c7-4510-8bda-e475022b59f5 pp1–4; https://runway.adityaperswal.workers.dev/data/stock-snapshots .

Premises:1 PLAY June15 Q1 actuals https://www.sec.gov/Archives/edgar/data/1525769/000152576926000026/play-20260505.htm show OCF113.8m lesscapex105.3m =8.5m, versus adjustedFCF25.3m after16.8msaleleasebackfinancing.66.40%adjustedfigurecomesfromassetfinancing; lowercapexvs154.6mpriorhelpscashwhilecomps-5.4% andentertainmentrevenue-5.865%.2 June15issuerrelease https://daveandbusters.gcs-web.com/news-releases/news-release-details/dave-busters-reports-first-quarter-2026-financial-results EBITDAmargin22.031%vs23.974%,creditEBITDA/interest~3.00x,19.6mcash vs1535.3mdebt; liquidity499.1mincludesrevolver.3 Aug4CEOchange toHarper https://www.sec.gov/Archives/edgar/data/1525769/000152576926000032/play-20260803.htm doesnotverifyQ2turnaround.4 EGTXAug21 https://www.egetis.com/mfn_news/egetis-interim-report-q2-2026/ confirmsSep28PDUFA but Q2totalcashflow230.2mSEKwith350mgrossraise; subtractinggrossraise=-119.8misroughfinancingbridge,NOTauditedoperatingburn. Revenue17.4mvs14.5m=20%reported/+23%CER; USexpandedaccesspatientsnotcommercialrevenue. CONCLUSION nofundamentalbuyfromheadlinecashorFDAdate. Validity: factsundercutcashqualityclaim,notprovefutureloss. Countercase: lowercapex,foodgrowth+6.464%,USapproval/PRVcouldimprovereturns; needpersistentsame-storecashandactualapprovaleconomics. No intrinsicvalueorapprovalprobabilityestimated; approximateequitymultiplesusingstalesharesdiscarded.

Premises:1 Large observed ranges may reflect completed news rather than unpriced future uncertainty.2 Operating growth does not determine option fair value without future return distribution and ask-to-bid costs.3 Cross-market fund NAV uses valuation timing distinct from local closes. IOT Sep3 issuer quarter endedAug1: revenue508.437m,ARR2124.7m +30%;GAAP operating4.875m versusadjusted106m,FCF64.7m versusSBC96.385m. Calculate GAAP operating margin0.959%;SBC/revenue18.96%. Underlying Sep4 IEX range14.43% follows released results; raising diffusion forecast from this gap risks treating completed catalyst as recurrent. SNDK Aug5 issuer:Q4revenue8965m,+51%q/q mostlypricing;84.6%GM;FCF7083m vs adjusted5035m after110mJV and1938mcustomerpayment deductions. Gross cash should not be capitalized as recurring without adjustments. Sep4IEXclose1739.915/FYGAAPEPS73.76 gives23.59x trailing reportedEPS, not prospective fairvalue; high cyclicalmargins maynormalize. EWJ issuerSep4NAV98.07,close98.28,premium0.22%,PE19.26; systematicfairvaluation means Japan/NYclock mismatch not parity. Strong countercase: durable customer adoption or contracted memorypayments could sustain growth and futurevol; that is a hypothesis, not known optionedge. Soundness based on original issuer documents, economically interested sources; no independent customer validation obtained. Facts end at historical figures; distributions/cash durability are assumptions. These checks constrain model interpretation, do not justify stock purchases outside mispricing mandate. Sources https://www.sec.gov/Archives/edgar/data/1642896/000162828026060438/samsaraepr-q22027.htm ; https://investor.sandisk.com/news-releases/news-release-details/sandisk-reports-fiscal-fourth-quarter-2026-financial-results ; https://www.ishares.com/us/products/239665/ishares-msci-japan-etf .

Premises:1 Officialdeveloper docs explainfees collected andUNI burned sinceDec2025, noactiveinflation butgovernancecanmintupto2%annual.2 July7Labsproposalclaims11-chainv2/v3fees andJunepeak186000UNI/day.3 No measuredcurrent30dayburn,totalcurrentsupply,retentionorv4executionreceipt tonight. Conclusionwatch tokenfundamentals; no fairvalueorentryfrompeakburn. Rate versus total:186000peak=.0186%of1bnlaunchsupply; 365xwould67.89m/6.789%but explicitly INVALID steady-rateforecast. RevenuevolumeisnotLP-independentcash:higherfeescanchange routing andliquidity. Counterexample stickyliquiditycouldpreservevolumeandstrengthenburn; needeventlogs andmatchedbeforeafterfees/volume tojudge. Configdocsselectedv3 versusJulyallpoolsapparentlydifferentvintages, not independentcorroboration. First orderfeeassetsfundburn; secondorderLPnetyieldandroutingmayrespond; thirdorderretentiondeterminesdurabletokendemand. PromoterbenefitUNIholders/labs, opportunitycostLPs. RejectclaimSept8UNI3.76%move causedbyJulyproposal withouttimednewinformation. Source https://gov.uniswap.org/t/temp-check-activate-v4-protocol-fees/26162 ; https://developers.uniswap.org/docs/ecosystem/governance/uni ; https://developers.uniswap.org/docs/protocols/protocol-fee/concepts/fees . No independentnumericaltradingedgeyet; sizezero.

1. Dated issuer observations9843–9853 establish actual material/cable operating profits, not simply scarcity headlines. ATI H1 simpleFCF136.2m and no >10% customer are favorable; endmarket concentration, raw-material lag and266m inventory cashuse qualify that inference. https://www.sec.gov/Archives/edgar/data/1018963/000162828026010140/ati-20251228.htm ; https://ir.atimaterials.com/news-events/news-details/2026/ATI-Announces-Second-Quarter-2026-Results/default.aspx . 2. HWM cash479m contrasts CRS quarterly155m cash after larger brownfield spending; stronger profits can coexist with weaker freecash. https://www.howmet.com/press-release/2026-08-06/howmet-aerospace-reports-second-quarter-2026-results/ ; https://www.ir.carpentertechnology.com/news-events/news/news-details/2026/Carpenter-Technology-Reports-Fourth-Quarter-and-Fiscal-Year-2026-Results/default.aspx . 3. IREN firmfuturecapacity is economically promising, but operating-to-contractedARR ratio25% describes delivery gap, not recognized revenue conversion. https://www.globenewswire.com/news-release/2026/08/27/3352401/0/en/iren-reports-fy26-results.html . 4. Prysmian transmission expansion and SKhynix shippedHBM support upstream capture; do not infer sustainable valuation from peakmargin, acquired growth or unmatched currencies. https://www.prysmian.com/en/media/press-releases/prysmian-raises-guidance-after-its-best-quarter-yet ; https://news.skhynix.com/en/q2-2026-business-results/ . 5. NX strongestdailygainer but issuer normal seasonality offers no demonstratedbottleneck; CCJ disruptions without annualguidancecut reject newlostsupply claim. https://investors.quanex.com/news-releases/news-release-details/quanex-building-products-announces-third-quarter-2026-results ; https://www.cameco.com/media/news/cameco-reports-2026-second-quarter-results . Validity: documented margins establish capture inreportedperiod, not futurestockalpha. Soundness: unauditedquarterly and issuer incentives, mixedperiods and cashdefinitions; not independent corroboration across copied articles. Startcash278.67;goalevidencedpositivepayoff;bindingconstraint independentlyvalidatedtiming andcashaftercapacity. Priorprobabilitynot numericallycalibrated; prospectivepositivecash/newacceptedcapacity moves fundamentalwatchup, supplierdefault/financingdeterioration movesdown; neither converts into stockwinprobability.

1.IssuerJune30factsheet https://www.ssga.com/library-content/products/factsheets/etfs/us/factsheet-us-en-spy.pdf statesexpense.0945%annual,FY1P/E22.50,504holdings,P/B5.49,indexdividendyield1.12%;reciprocalearningsyield4.4444% is forecastvaluation arithmetic,not realizedcashyield orSeptember8valuation. 2.Jan27SECprospectus withattachedJan26USprospectus https://www.sec.gov/Archives/edgar/data/884394/000119312526023648/d935960d497.htm establishesindexownership and50000-sharecreationunits;this245.69book usessecondarymarket,notAPredemption economics. 3.No companyearningscashclaim paysspecificallybecausecalendarturnarrives. Fundexpensesalreadyembedded inhistoricalETFprices,notdoublecharged. Atassumed20bproundtrip,12roundtripscost2.3738%compounded onallocatedcapitalbeforemarketreturns,faraboveannualwrapperexpense; actualvenuefees unverified. 4.Bearcaseforcash:itforgoes equityearningsgrowth andriskpremium;bearcaseforentry:thediversifiedassetcanstill beexpensive orfall,andcalendarhasnovalidatednettimingedge. No valuationpremium is converted intoa4-sessionprice target. Facts aredatedissuerdisclosures;futureEPS,flowsandcurrentfairvalueunknown.

Premises1 observation9285 issuer sharecounts remainSep4 IBIT1384960000/ETHA464560000, no freshsharechange;2 benchmarkprices datedSep7 differ fromsharedate;3 Sep3protocolcall retainsOct6Sepolia andHoodideferred. Conclusion no newETFfloworimmediateupgradepayoff toacton. Validity: sharecountmeasurementdate bounds inference; soundness: issuerdatasets omitotherETFs andOTCdemand, so absenceofnewdata isnotzeroglobalflows. Strongest bullcase: primarycreationsreturn afterholiday andimprovedprotocolcapacity supportsactivity. Bearcase: anticipation precedesusage, rollout risks persist andcheapexecutionneednot accruevalue totoken. Firstorder proposedcapacity/reliability changes;secondorder users andapplications may migrate orpaylowerfees;thirdorder tokendemand/burn mayriseorfall depending volume elasticity. No discountedcashflow assignedwithoutfee/burnhistory or tokenholdercashclaim. Beneficiaries of fees include venues/sponsors, notautomaticallycoinholders. Existingmonitors35/37/44 retained; neitherdateisautomaticentry. Sources https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf ; https://www.ishares.com/us/products/337614/ishares-ethereum-trust-etf ; https://ethereum-magicians.org/t/all-core-devs-consensus-acdc-186-september-3-2026/29496 . Priorwatchunchanged; freshnormalizedsharecreationplusindependentreturnvalidation would change assessment. Stablecoin supply/exchangeflow notmeasured thisbranch; circulating supplyalonecannotidentifyspotbuying.

1. GEV July22 Q2 gas backlog/reservations116GW establishes OEM demand, not BWEN firm orders: https://www.gevernova.com/news/articles/ge-vernova-releases-second-quarter-2026-financial-results . 2. BWEN Aug11 Q2 continuing revenue24.303m, IS operatingprofit2.339m on13.172m sales, Gearing loss.224m, corporate/other loss2.362m: https://investors.bwen.com/investor-news/investor-news-details/2026/Broadwind-Announces-Second-Quarter-2026-Results/default.aspx . Python margins17.757%/-2.477%/-1.016%; bookbill1.450. 3. H1 continuing CFO-.871m minuscapex3.232m=-4.103m; annualized-8.206m is arithmetic notforecast. Cash17.043m follows disposal proceeds17.154m and discontinuedcashflows; cashbuild not recurring earnings: https://www.sec.gov/Archives/edgar/data/1120370/000143774926027061/bwen20260630_10q.htm . 4. March11 annualreport2025 top5customers80%revenue/59%A/R,GEV>10%; customer cancellation, verticalintegration, adversepricing/paymentterms and deliverydamages; multiple-source inputs withoutlongtermagreements: https://www.sec.gov/Archives/edgar/data/1120370/000143774926007742/bwen20251231_10k.htm . Postdisposal customer mix unknown; don't project80%unchanged. Strongest bull: increasedutilization andISprofit cancoverfixedcostsoon. Counterexample: bargaining power andcapex consumeincrementalprofit. Validity: OEMdemanddoesnotentailshareholdercash; soundness supportedbycurrentcashbridge, notproof futurefailure. Bindingconstraint is sustainedcontinuingcashconversion plus independentstockedge. VerifiedpositiveFCF/firmcustomerterms wouldadvancewatch; no calibrated probabilityfrombacklog alone.

Premises:1 July23 issuer FY26 FCF436m includes >400m property-sale proceeds; FY27 FCFguide35–40m https://investor.scholastic.com/news-releases/news-release-details/scholastic-reports-fourth-quarter-and-fiscal-2026-results .2 EBITDA151.5m versus132.4m proforma means135–145m guide is comparable growth, not automatically a cut.3 August27 transaction filing: estate sold289624shares privately for11.5155m; remaining158.9m authorization is optional https://www.sec.gov/Archives/edgar/data/866729/000119312526371245/schl-20260827.htm . Conclusion: reject extrapolating asset proceeds or interpreting private repurchase as persistent market demand. Valid inference; soundness limited by unknown coming-quarter cash, lease-adjusted valuation and future execution. Strong countercase: buybacks reduce share count and cash-generating book fairs can improve shareholder value. Who benefits: estate receives liquidity, remaining holders own larger fraction; landlords gain rent. Neither establishes five-session run-up edge. Freshness: documents are July/August, reread September8; not new operating news today.

Premises: 1 Sep6 issuer fixes Sep8 ERS06:15ET and investorcall08ET: https://investor.roivant.com/news-releases/news-release-details/roivant-present-topline-results-phase-2-phocus-study-mosliciguat . 2 Sponsor registry https://clinicaltrials.gov/api/v2/studies/NCT06635850 lastupdatedFeb20 has135actualparticipants,randomizedparallel/quadruplemasking,week16PVRprimary,6MWTdistance/NTproBNPsecondaries. Feb6 sponsor https://www.pulmovant.com/press-release-february-6-2026 describedapproximately120; actual count andlaterdate explain difference. EstimatedDecembercompletion is stale relative to Septembernotice; it does not negate presentation, but actualcutoff andcompleteness must be verified. 3 Aug6 10Q https://www.sec.gov/Archives/edgar/data/1635088/000163508826000090/roiv-20260630.htm June30cash/securities3842.082m,quarterCFOoutflow270.504m (+32.35%YoY),SBC83.342m,repurchases206.729m. Burnrate annualized1082.016m; static cash/burn14.20quarters is arithmetic,notforecast. Subsequent July8Genevant771.6mreceipt is separate fromJune30cash; total950mrecipient amount includesArbutus. Pulmovantownership97%basic/90%FD. July31shares722323015 timesSep4IEX34.945 implies25.242bnmixed-dateequityvalue; June30grosscash5.319/share or15.22% ofthatvalue,notparentNAV. 4 BrepocitinibalreadyapprovedAug27 https://investor.roivant.com/news-releases/news-release-details/priovant-announces-fda-approval-lisrayatm-brepocitinib-adults ; earlier10QpendingQ3language is superseded. CONCLUSION prospectivePHocusreviewonly,size0. Attack: strongcash andacutePVRmechanismcouldsupportdevelopment, but neither establishes sustainedfunctionalbenefit orcommercialeconomics. Valid inference distinguishes finance,physiology andpayoff; soundness limited by sponsorreporting,one-quarterburn,minorityinterests andno completevaluation/reimbursementmodel. Facts end atfilings/design; successprobabilitynotestimated.

1. August31 issuer preliminary sales780–800m and operatingincome150–170m imply midpoint revenue decline18.741% yet operatingmargin20.253% versus6.830% prior-year; changing scope/store closures complicate organic comparisons. 2. Net eBay/digital investment gains163m equal54.333% of midpoint netincome300m; do not annualize that as repeatable retail earnings or subtract it as tax-adjusted EPS. 3. Cash/securities midpoint5060m is down41.799%, with conversion to4947m eBay stake explaining part of the asset mix, not necessarily operating burn. Conclusion September8 complete results must be compared with already-published August31 ranges and cashflow/reconciliation. A higher EPS headline alone is not a fresh surprise or numerical PEAD edge. Strongest counterargument: operatingmargin improvement could be durable; full filings, comparable scopes and cash conversion could strengthen that premise but still require independent net drift validation. Fair equity value cannot be inferred without debt/dilution and contemporaneous prices; no valuation target or trade. Source https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx . Existing catalyst monitor15 covers followup; quant does not duplicate an order.

Premises: 1. On September7 the issuer pages still date IBIT's1,384,960,000 and ETHA's464,560,000 shares to September4. Those unchanged dated records do not establish zero flow since then; no newer measurement exists here. 2. Publishing agencies confirm September8 Census Q2 financial reports10ET, NYFed consumer expectations11ET, Fed consumer credit15ET; September9 BLS June employer compensation and Census Q2 services10ET. PPI/CPI September10/11 fall outside these two sessions. 3. September3 Ethereum developer decision places Sepolia onOctober6, not September9; mainnet timing unverified. Conclusion: calendar sets research checkpoints, not expected returns. Counterexample: an unanticipated macro surprise can move crypto sharply; without a calibrated conditional price model its direction/magnitude cannot justify an order. First transmission assumption: inflation/credit news can change rates/liquidity expectations; next leveraged positioning responds; then spot demand may shift. No quantified causal coefficient adopted. Existing monitors44/45 retained, next-run12:30UTC review57 added. Earnings/FDA company-specific events lie outside this crypto edge unless a documented transmission emerges; no such trade proposed. Sources https://www.newyorkfed.org/research/calendars/i-sep26.html ; https://www.federalreserve.gov/newsevents/2026-september.htm ; https://www.bls.gov/schedule/2026/ ; https://www.census.gov/economic-indicators/calendar-listview.html ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf ; https://www.ishares.com/us/products/337614/ishares-ethereum-trust-etf ; https://ethereum-magicians.org/t/all-core-devs-consensus-acdc-186-september-3-2026/29496 .

Premises:1 Event model must align firstpublicnews.2 Preannounced results reduce the amount of wholly unknown information, without necessarily eliminating event risk.3 Clinicalreadouts are not FDAdecisions. Primary issuer/agency observations8889–8904 datedSep7, eachorigin countedonce. Sep8 INBX08ETclinicalwebcast; CensusQ2QFR10ET, NYFedSCE11ET, FedG19consumercredit15ET; BRZEafterclose/16:30ETcall; GMEcompleteresultsdateonly. Sep9 CHWYbeforeopen/08ETcall,ASObeforeopen/10ETcall,TYRA08ETclinicalwebcast; JuneECEC/Q2QSS10ET; EIASTEOdateonly. PPI/CPI Sep10/11,TLXPixclaraSep11 outsidewindow; no exhaustiveFDAabsenceclaim. CASYSep8afterclose andIRD/InditexSep9 remaincontext, not independentlyrevalidated thisrun; CASYPDF200 but readerunavailable. GMEAug31 unauditedQ2sales780–800m versus972.2m,operatingincome150–170m versus66.4m; netincome290–310m includes238meBaygain/75mdigitalloss. Inference: unconditional past earningsgap variance may not describe residualSep8uncertainty. Counterexample: completefilings/newguidance may still moveprice materially, so no zeroeventvarianceassumption. No issuervaluation or per-name optioncandidate inferred; insufficientcurrentfundamental/chainaudit prevents promotion. Sources https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx ; https://www.census.gov/economic-indicators/calendar-listview.html ; https://www.bls.gov/schedule/2026/ ; https://www.federalreserve.gov/newsevents/2026-september.htm ; https://www.newyorkfed.org/research/calendars/i-sep26.html ; https://www.eia.gov/outlooks/steo/outlook.php ; exact issuer URLs inobservations8894–8902. Promotionalclaims not adopted; dates are plans not realized surprises. First attempt to record failed overlong figurekey; this is corrected record.